Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Mineralys Therapeutics, Inc. (MLYS) had Cash Flow from Investing Activities of $-135.76M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-43.27M |
|
-- |
|
-- |
|
$46.75M |
|
$-46.75M |
|
$3.47M |
|
$-43.27M |
|
$-43.27M |
|
$-43.27M |
|
$-43.27M |
|
$-43.27M |
|
$-43.27M |
|
$-46.75M |
|
$-46.73M |
|
65.45M |
|
65.45M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$335.27M |
|
$0.02M |
|
$0.46M |
|
$335.72M |
|
$22.17M |
|
-- |
|
-- |
|
$22.17M |
|
$313.55M |
|
$313.55M |
|
$313.55M |
|
65.72M |
|
| Cash Flow Statement Financials | |
$-75.66M |
|
|
Cash Flow from Investing Activities |
$-135.76M |
$199.11M |
|
$114.09M |
|
$101.79M |
|
$-12.30M |
|
$8.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-75.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.80% |
|
-13.80% |
|
-12.89% |
|
-13.80% |
|
$4.77 |
|
$-1.16 |
|
$-1.16 |
|